Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 Jul;88(3):355–362. doi: 10.1046/j.1365-2567.1996.d01-672.x

Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

J P Drenth 1, J Göertz 1, M R Daha 1, J W van der Meer 1
PMCID: PMC1456352  PMID: 8774350

Abstract

Immunoglobulin D (IgD) is normally present in only low concentrations in serum. In the hyper-IgD and periodic fever syndrome (HIDS), however, serum levels exceed 140 mg/l. This syndrome is further characterized by recurrent inflammatory febrile attacks together with an acute phase response and appearance of cytokines in the circulation. The role of IgD in the pathogenesis of HIDS and its relation to the increased cytokine concentrations is unclear. Therefore, we tested whether IgD, IgG and alpha 1-acid glycoprotein (AGP) isolated from human serum influence the synthesis of interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), and IL-1ra, as measured by specific radioimmunoassays, in human peripheral blood mononuclear cells (PBMC). Incubation of PBMC with IgD and AGP for 24 hr led to increased release of IL-1 beta, TNF-alpha, and IL-lra. The magnitude of stimulation of IgD exceeded that of AGP; the effect by IgD was dose-dependent and showed a 30-fold (TNF-alpha) to almost 150-fold (IL-1 beta) increase at the highest concentration (50 mg/l), while AGP (750 micrograms/ml) only increased the cytokine secretion fourfold (TNF-alpha) to almost 30-fold (IL-1 beta). The effect of IgD on IL-1ra was less dramatic but a fivefold increase was observed at 50 mg/l compared with a 2.5-fold increase with AGP. IgD potentiated the effect of lipopolysaccharide (LPS) on secretion of both IL-1 beta and TNF-alpha, although the effect was most apparent for TNF-alpha. Apart from inducing IL-1ra synthesis, IgG did not influence cytokine release in human PBMC. These data indicate that IgD is a potent inducer of TNF-alpha, IL-1 beta and IL-1ra and thus may contribute to the pathogenesis of HIDS.

Full text

PDF
355

Images in this article

358Figure 1
on p.358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amin A. R., Tamma S. M., Oppenheim J. D., Finkelman F. D., Kieda C., Coico R. F., Thorbecke G. J. Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9238–9242. doi: 10.1073/pnas.88.20.9238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arend W. P., Joslin F. G., Massoni R. J. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol. 1985 Jun;134(6):3868–3875. [PubMed] [Google Scholar]
  3. Arend W. P., Smith M. F., Jr, Janson R. W., Joslin F. G. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. J Immunol. 1991 Sep 1;147(5):1530–1536. [PubMed] [Google Scholar]
  4. Ballou S. P., Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine. 1992 Sep;4(5):361–368. doi: 10.1016/1043-4666(92)90079-7. [DOI] [PubMed] [Google Scholar]
  5. Boutten A., Dehoux M., Deschenes M., Rouzeau J. D., Bories P. N., Durand G. Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol. 1992 Oct;22(10):2687–2695. doi: 10.1002/eji.1830221032. [DOI] [PubMed] [Google Scholar]
  6. Coico R. F., Tamma S. L., Bessler M., Wei C. F., Thorbecke G. J. IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. J Immunol. 1990 Dec 1;145(11):3556–3561. [PubMed] [Google Scholar]
  7. Coico R. F., Tamma S. L., Bessler M., Wei C. F., Thorbecke G. J. IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. J Immunol. 1990 Dec 1;145(11):3556–3561. [PubMed] [Google Scholar]
  8. Drenth J. P., Haagsma C. J., van der Meer J. W. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 1994 May;73(3):133–144. [PubMed] [Google Scholar]
  9. Drenth J. P., Powell R. J., Brown N. S., Van der Meer J. W. Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Clin Invest. 1995 Sep;25(9):683–686. doi: 10.1111/j.1365-2362.1995.tb01986.x. [DOI] [PubMed] [Google Scholar]
  10. Drenth J. P., Van Uum S. H., Van Deuren M., Pesman G. J., Van der Ven-Jongekrijg J., Van der Meer J. W. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol (1985) 1995 Nov;79(5):1497–1503. doi: 10.1152/jappl.1995.79.5.1497. [DOI] [PubMed] [Google Scholar]
  11. Drenth J. P., van Deuren M., van der Ven-Jongekrijg J., Schalkwijk C. G., van der Meer J. W. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood. 1995 Jun 15;85(12):3586–3593. [PubMed] [Google Scholar]
  12. Hao Y. L., Wickerhauser M. Development of large-scale fractionation methods. IV. A simple method for the large-scale preparation of alpha1-acid glycoprotein. Biochim Biophys Acta. 1973 Sep 21;322(1):99–108. doi: 10.1016/0005-2795(73)90180-3. [DOI] [PubMed] [Google Scholar]
  13. Haraldsson A., Weemaes C. M., De Boer A. W., Bakkeren J. A., Stoelinga G. B. Immunological studies in the hyper-immunoglobulin D syndrome. J Clin Immunol. 1992 Nov;12(6):424–428. doi: 10.1007/BF00918854. [DOI] [PubMed] [Google Scholar]
  14. Havenaar E. C., Drenth J. P., van Ommen E. C., van der Meer J. W., van Dijk W. Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation. Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 1):279–284. doi: 10.1006/clin.1995.1126. [DOI] [PubMed] [Google Scholar]
  15. Heukeshoven J., Dernick R. Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis. 1988 Jan;9(1):28–32. doi: 10.1002/elps.1150090106. [DOI] [PubMed] [Google Scholar]
  16. Jancelewicz Z., Takatsuki K., Sugai S., Pruzanski W. IgD multiple myeloma. Review of 133 cases. Arch Intern Med. 1975 Jan;135(1):87–93. [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Morin M., Schindler R., Wakabayashi G., Daumy G., Dinarello C. A., Gelfand J. A. Picogram concentrations of endotoxin stimulate synthesis of IL-1 beta and TNF alpha by human peripheral blood mononuclear cells exposed to recombinant human C5a. Eur Cytokine Netw. 1991 Jan-Feb;2(1):27–30. [PubMed] [Google Scholar]
  19. Müller-Alouf H., Alouf J. E., Gerlach D., Ozegowski J. H., Fitting C., Cavaillon J. M. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun. 1994 Nov;62(11):4915–4921. doi: 10.1128/iai.62.11.4915-4921.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Poutsiaka D. D., Clark B. D., Vannier E., Dinarello C. A. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood. 1991 Sep 1;78(5):1275–1281. [PubMed] [Google Scholar]
  21. ROWE D. S., FAHEY J. L. A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN. J Exp Med. 1965 Jan 1;121:171–184. doi: 10.1084/jem.121.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Roes J., Rajewsky K. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med. 1993 Jan 1;177(1):45–55. doi: 10.1084/jem.177.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rogentine G. N., Jr, Rowe D. S., Bradley J., Waldmann T. A., Fahey J. L. Metabolism of human immunoglobulin D (IgD). J Clin Invest. 1966 Sep;45(9):1467–1478. doi: 10.1172/JCI105454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rowe D. S., Anderson S. G., Tackett L. A research standard for human serum immunoglobulin D. Bull World Health Organ. 1970;43(4):607–609. [PMC free article] [PubMed] [Google Scholar]
  25. Schindler R., Dinarello C. A. A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immunol Methods. 1989 Jan 17;116(2):159–165. doi: 10.1016/0022-1759(89)90199-3. [DOI] [PubMed] [Google Scholar]
  26. Schindler R., Gelfand J. A., Dinarello C. A. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood. 1990 Oct 15;76(8):1631–1638. [PubMed] [Google Scholar]
  27. Skvaril F., Rádl J. The fragmentation of human IgD during storage. Clin Chim Acta. 1967 Mar;15(3):544–546. doi: 10.1016/0009-8981(67)90023-x. [DOI] [PubMed] [Google Scholar]
  28. Tamma S. M., Amin A. R., Finkelman F. D., Chen Y. W., Thorbecke G. J., Coico R. F. IgD receptors on murine T-helper cells bind to Fd and Fc regions of immunoglobulin D. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9233–9237. doi: 10.1073/pnas.88.20.9233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tilg H., Vannier E., Vachino G., Dinarello C. A., Mier J. W. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993 Nov 1;178(5):1629–1636. doi: 10.1084/jem.178.5.1629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van Deuren M., Dofferhoff A. S., van der Meer J. W. Cytokines and the response to infection. J Pathol. 1992 Dec;168(4):349–356. doi: 10.1002/path.1711680403. [DOI] [PubMed] [Google Scholar]
  31. van der Meer J. W., Endres S., Lonnemann G., Cannon J. G., Ikejima T., Okusawa S., Gelfand J. A., Dinarello C. A. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol. 1988 Mar;43(3):216–223. doi: 10.1002/jlb.43.3.216. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES